Annual Drug Patent Expirations for OZEMPIC
Ozempic is a drug marketed by Novo and is included in one NDA. It is available from two suppliers. There are twenty-five patents protecting this drug.
Drug patent litigation for OZEMPIC.
This drug has two hundred and four patent family members in twenty-eight countries.
The generic ingredient in OZEMPIC is semaglutide. Two suppliers are listed for this compound. Additional details are available on the semaglutide profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
